Omicron: GlaxoSmithKline announces UK-approved drug for new variant
GlaxoSmithKline says a pre-clinical analysis of its antibody-based COVID-19 therapy developed with U.S. partner Vir has yielded positive results against newly identified Omicron variant.
The pharmaceutical company on Thursday said in a statement that further tests will be carried out on the Sotrovimab therapy to firm up the results.
George Scangos, Chief Executive Officer of Vir, said: “Sotrovimab was deliberately designed with a mutating virus in mind.
“By targeting a highly conserved region of the spike protein that is less likely to mutate, we hoped to address both the current SARS-CoV-2 virus and future variants that we expected would be inevitable.”
This news comes as the UK’s drug regulator approved GSK and Vir Biotechnology’s Xevudy treatment, after findings revealed it to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 infection.
The antibody therapy reduced the risk of hospitalisation and death by 79 per cent in high-risk adults with symptomatic COVID-19 infection during its clinical trials.
Though the UK has already ordered around 100,000 doses of the drug, its Medicines and Healthcare Products Regulatory Agency said it would work with GSK to establish if Omicron will have any impact on its efficacy.
Sotrovimab is authorised for emergency use in the United States and in Japan, and has been approved via the Special Approval for Emergency Pathway.
The Omicron variant, identified first in South Africa, has been listed as a ‘variant of concern’ and said it could take several weeks to know if there are significant changes in transmissibility, severity or implications for COVID-19 vaccines, tests, and treatments.
The new mutation, which shows resistance to the vaccine and built up immunity, has been identified in multiple countries including Nigeria.
This has led to multiple flight bans and red list placements as governments race to contain the spread of the new variant.
More from Peoples Gazette
Africa
Transparency International urges multinational investigation of Senegal oil fraud
The anti-corruption body notes that Senegalese authorities have been stalling on fully investigating the situation and holding perpetrators accountable.
Agriculture
Aiteo oil leak in Nembe worse than Gulf of Mexico spill: Gov. Diri
“Today happens to be a very dark day for me. What we have seen, I believe, is worse than what happened in the Gulf of Mexico. In all my life…,” the governor stated.
States
2023: Dark horses trying to destroy APC, says Patriotic Association
“There are some dark horses trying to destroy the party before the 2023 general elections if things do not go their way,” said Mr Nabature.
Economy
Eighty-nine billion naira generated in November at Apapa: Customs
“This feat is coming after the command generated N86 billion in the month of October following improved inter-agency synergies…and prevention of revenue loss.”
States
CAN condemns attack on Jos prison, says Nigeria’s security under threat
The religious body said among the escapees are hardened criminals who “will go back into the society and continue to unleash evil.”
States
Ebonyi HIV rate reduces by 0.8%
According to the Ebonyi official, the agency recorded the prevalence rate of 9.3 per cent in 2001, 6.3 per cent in 2003, 5.8 per cent in 2005, 4.3 per cent in 2008.
